198 related articles for article (PubMed ID: 29282008)
21. Burden of lung cancer deaths due to smoking for men and women in the WHO Western Pacific and South East Asian regions.
Martiniuk A; Lee CM; Woodward M; Huxley R
Asian Pac J Cancer Prev; 2010; 11(1):67-72. PubMed ID: 20593933
[TBL] [Abstract][Full Text] [Related]
22. Implications of external price referencing of pharmaceuticals in Middle East countries.
Kaló Z; Alabbadi I; Al Ahdab OG; Alowayesh M; Elmahdawy M; Al-Saggabi AH; Tanzi VL; Al-Badriyeh D; Alsultan HS; Ali FM; Elsisi GH; Akhras KS; Vokó Z; Kanavos P
Expert Rev Pharmacoecon Outcomes Res; 2015; 15(6):993-8. PubMed ID: 26088919
[TBL] [Abstract][Full Text] [Related]
23. Price comparison of high-cost originator medicines in European countries.
Vogler S; Zimmermann N; Babar ZU
Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):221-230. PubMed ID: 27658050
[TBL] [Abstract][Full Text] [Related]
24. The Availability, Pricing, and Affordability of Essential Diabetes Medicines in 17 Low-, Middle-, and High-Income Countries.
Babar ZU; Ramzan S; El-Dahiyat F; Tachmazidis I; Adebisi A; Hasan SS
Front Pharmacol; 2019; 10():1375. PubMed ID: 31824316
[No Abstract] [Full Text] [Related]
25. A global comparison of the cost of patented cancer drugs in relation to global differences in wealth.
Goldstein DA; Clark J; Tu Y; Zhang J; Fang F; Goldstein R; Stemmer SM; Rosenbaum E
Oncotarget; 2017 Sep; 8(42):71548-71555. PubMed ID: 29069727
[TBL] [Abstract][Full Text] [Related]
26. Relationship between pharmaceutical pricing strategies with price, availability, and affordability of cardiovascular disease medicines: surveys in Qatar and Lebanon.
Abdel Rida N; Mohamed Ibrahim MI; Babar ZUD
BMC Health Serv Res; 2019 Dec; 19(1):973. PubMed ID: 31852546
[TBL] [Abstract][Full Text] [Related]
27. 60 Years after Kefauver: Household income required to buy prescription drugs in the United States and abroad.
Mattingly TJ; Seo D; Ostrovsky AM; Vanness DJ; Conti RM
Res Social Adm Pharm; 2021 Aug; 17(8):1489-1495. PubMed ID: 33221266
[TBL] [Abstract][Full Text] [Related]
28. Anticancer drug prices and clinical outcomes: a cross-sectional study in Italy.
Trotta F; Mayer F; Barone-Adesi F; Esposito I; Punreddy R; Da Cas R; Traversa G; Perrone F; Martini N; Gyawali B; Addis A
BMJ Open; 2019 Dec; 9(12):e033728. PubMed ID: 31826897
[TBL] [Abstract][Full Text] [Related]
29. Mapping the selection, availability, price and affordability of essential medicines for mental health conditions at a global level.
Todesco B; Ostuzzi G; Barbui C
Epidemiol Psychiatr Sci; 2022 Apr; 31():e22. PubMed ID: 35438063
[TBL] [Abstract][Full Text] [Related]
30. Pricing and Paying for Cancer Drugs: Policy Options for Fixing A Broken System.
Hyman DA; Silver C
Cancer J; 2020; 26(4):298-303. PubMed ID: 32732672
[TBL] [Abstract][Full Text] [Related]
31. Raising cigarette excise tax to reduce consumption in low-and middle-income countries of the Asia-Pacific region:a simulation of the anticipated health and taxation revenues impacts.
Ho LM; Schafferer C; Lee JM; Yeh CY; Hsieh CJ
BMC Public Health; 2018 Oct; 18(1):1187. PubMed ID: 30340557
[TBL] [Abstract][Full Text] [Related]
32. The level of income appears to have no consistent bearing on pharmaceutical prices across countries.
Morel CM; McGuire A; Mossialos E
Health Aff (Millwood); 2011 Aug; 30(8):1545-52. PubMed ID: 21821572
[TBL] [Abstract][Full Text] [Related]
33. Comparative Analysis of Prescription Drug Prices in South Asian Association for Regional Cooperation Countries.
Rohra DK; Abuomar OA; Cahusac PMB; Dangol A; Ranasinghe P
Value Health Reg Issues; 2020 May; 21():113-119. PubMed ID: 31706178
[TBL] [Abstract][Full Text] [Related]
34. Price differentials of tobacco products: A cross-sectional analysis of 79 countries from the six WHO regions.
Kyriakos CN; Ahmad A; Chang K; Filippidis FT
Tob Induc Dis; 2021; 19():80. PubMed ID: 34720795
[TBL] [Abstract][Full Text] [Related]
35. The impact of pricing strategy on the costs of oral anti-cancer drugs.
Truong J; Chan KKW; Mai H; Chambers A; Sabharwal M; Trudeau ME; Cheung MC
Cancer Med; 2019 Jul; 8(8):3770-3781. PubMed ID: 31132223
[TBL] [Abstract][Full Text] [Related]
36. External Reference Pricing for Pharmaceuticals-A Survey and Literature Review to Describe Best Practices for Countries With Expanding Healthcare Coverage.
Holtorf AP; Gialama F; Wijaya KE; Kaló Z
Value Health Reg Issues; 2019 Sep; 19():122-131. PubMed ID: 31416014
[TBL] [Abstract][Full Text] [Related]
37. A comparison of publication to TBI burden ratio of low- and middle-income countries versus high-income countries: how can we improve worldwide care of TBI?
Tropeano MP; Spaggiari R; Ileyassoff H; Park KB; Kolias AG; Hutchinson PJ; Servadei F
Neurosurg Focus; 2019 Nov; 47(5):E5. PubMed ID: 31675715
[TBL] [Abstract][Full Text] [Related]
38. International drug price comparisons: quality assessment.
Machado M; O'Brodovich R; Krahn M; Einarson TR
Rev Panam Salud Publica; 2011 Jan; 29(1):46-51. PubMed ID: 21390419
[TBL] [Abstract][Full Text] [Related]
39. The pan-Canadian Tiered Pricing Framework and Chinese National Volume-Based Procurement: A comparative study using Donabedian's structure-process-outcome framework.
Wang Q; Liu S; Nie Z; Zhu Z; Fu Y; Zhang J; Wei X; Yang L; Wei X
J Glob Health; 2023 Nov; 13():04137. PubMed ID: 37947028
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
